IDEXX Laboratories, Inc.
IDXX
주식 순위
#559
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing,... IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
주가
$556.46
마지막 동기화: 2026-10-20
시가총액
$43.84B
변동 (1일)
0.12%
변동 (1년)
-12.66%
국가
US
거래 IDEXX Laboratories, Inc. (IDXX)
카테고리
Healthcare
IDEXX Laboratories, Inc. (IDXX)의 수익
Jun 2026 기준 수익 TTM: $1.42B
IDEXX Laboratories, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익은 $1.42B입니다. 2024년에 회사는 $1.11B의 수익을 올렸으며 이는 2023년의 수익 $1.06B과 증가입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
IDEXX Laboratories, Inc.의 수익 기록 (2000 ~ 2026)
연말 수익
| 연도 | 수익 | 변화 |
|---|---|---|
| 2026 (TTM) | $1.42B | 7.57% |
| 2025 | $1.32B | 19.31% |
| 2024 | $1.11B | 4.59% |
| 2023 | $1.06B | 23.40% |
| 2022 | $859.97M | -4.73% |
| 2021 | $902.65M | 36.36% |
| 2020 | $661.99M | 26.76% |
| 2019 | $522.22M | 14.09% |
| 2018 | $457.74M | 20.12% |
| 2017 | $381.06M | 18.40% |
| 2016 | $321.85M | 17.83% |
| 2015 | $273.14M | 10.78% |
| 2014 | $246.56M | -6.35% |
| 2013 | $263.26M | 1.01% |
| 2012 | $260.62M | 11.17% |
| 2011 | $234.42M | 15.98% |
| 2010 | $202.13M | 15.81% |
| 2009 | $174.54M | 2.56% |
| 2008 | $170.19M | 26.21% |
| 2007 | $134.84M | 3.13% |
| 2006 | $130.75M | 10.36% |
| 2005 | $118.47M | 6.63% |
| 2004 | $111.10M | 33.45% |
| 2003 | $83.25M | 21.06% |
| 2002 | $68.77M | 16.99% |
| 2001 | $58.78M | 0.92% |
| 2000 | $58.25M | 0.00% |
유사 기업 또는 경쟁사의 수익
| 회사 | 수익 | 수익 차이 | 국가 |
|---|---|---|---|
| $7.61B | 434.18% |
US
|
|
| $4.76B | 234.31% |
US
|
|
| $-252.70M | -117.74% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 16.40% |
US
|
